RACHEL BROWN: Open Payments
NPI 1063828853 · SKOKIE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 80 payments from 18 companies in 2025. Trend: 2023 $983 · 2024 $1,734 · 2025 $1,716
Food & beverage: $1,716
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $282 |
| Otsuka America Pharmaceutical, Inc. | 5 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $185 |
| Axsome Therapeutics, Inc. | 7 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $149 |
| Lundbeck LLC | 8 | $147 |
| Noven Therapeutics, LLC | 8 | $135 |
| Alkermes, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Almatica Pharma LLC | 2 | $48 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, Xelstrym, LYBALVI, INGREZZA.
Industry payments across IL — which companies pay providers there.
